Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Commodities And Pharma Push FTSE 100 Below 6,000

Tue, 22nd Sep 2015 16:11

LONDON (Alliance News) - Stocks in London ended down Tuesday, with commodities-related stocks and pharmaceutical shares dragging down the FTSE 100, which ended below the 6,000 line for the first time in nearly a month.

The blue-chip index closed down 2.8% at 5,935.84 points, with all its constituents in the red except for RSA Insurance, which ended up 0.6%, a day after its shares tumbled 21% because Zurich Insurance pulled out of talks to buy the company.

The mid-cap FTSE 250 index declined 2.2% to 16,529.98, while the AIM All-Share ended down 1.3% at 730.51. European major indices also finished lower, with the CAC 40 in Paris down 3.4% and the DAX 30 in Frankfurt off 3.8%.

Shares in China closed higher as the Hang Seng index ended up 0.2% and the Shanghai Composite up 0.9%, while the Japanese market remained closed for holiday until Thursday.

In the US, stocks were in the red at the London close. The Dow Jones Industrial Average was down 1.7%, the S&P 500 down 1.7% and the Nasdaq Composite down 2.1%.

The strength of the dollar since the US Federal Reserve on Thursday last week decided to keep US interest rates on hold is hurting the price of commodities such as gold, silver and oil. The yellow metal retreated Tuesday to USD1,125.72 an ounce, while silver was down at USD14.79 per ounce.

The pound was lower against the dollar Tuesday at the London close, standing at USD1.5366, having traded at USD1.5558 before the Fed decision last week.

As a result, London-listed mining and oil-related stocks took yet another hit on Tuesday, with miners' misery exacerbated by a series of downgrades in the sector by Credit Suisse.

Antofagasta, down 6.6%, was cut to Underperform from Neutral, while Anglo American, 6.1%, was downgraded to Neutral from Outperform. Mid-cap KAZ Minerals, down 25%, was cut to Neutral from Outperform.

Others such as BHP Billiton, down 4.2%, and Rio Tinto, down 3.5%, also ended among the biggest fallers. Glencore was the worst performer in the FTSE 100, down 9.6% at 107.53 pence, having touched a new all-time low of 99.59p, the first time its price has gone below 100.00p.

Oil also was under pressure Tuesday. At the London close, Brent oil prices were down at USD47.85 a barrel, coming off the level of USD50.31 prior to the Fed announcement, while West Texas Intermediate stood at USD45.62 a barrel, having traded at USD47.68 before the Fed decision.

Oil stocks finished lower, with BG Group down 3.0%, Royal Dutch Shell 'B' shares down 3.1% and BP down 2.5%.

Outside of the commodities sector, London-listed pharmaceutical companies were out of favour after US presidential candidate Hillary Clinton tweeted about "price gouging" in the specialty drug market.

On her official Twitter account Monday, Clinton cited a New York Times article which said the price of the Daraprim drug, which treats a life-threatening parasitic infection, soared to USD750 a tablet from USD13.50 a tablet overnight.

Clinton, the frontrunner for the Democratic nomination, tweeted "price gouging like this in the specialty drug market is outrageous. Tomorrow I'll lay out a plan to take it on". Clinton was scheduled to make the announcement in Des Moines, Iowa, at 2 pm local time Tuesday, which is 2000 BST.

Shire ended down 5.0%, AstraZeneca down 4.4% and GlaxoSmithKline down 3.1%. The FTSE 100 drug makers all have significant US sales.

Engineering company GKN also was amongst the biggest fallers, down 6.1%, amid worries about knock-on effects of the emissions cheating scandal engulfing German car maker Volkswagen, the largest customer of GKN's Driveline business.

Though UBS said that the impact on GKN is likely to be "trivial", shares in the engineer touched a low it hasn't seen since early 2013.

Meanwhile, Johnson Matthey, the platinum group metals company that makes emission control technologies, lost 8.0%

Supermarket chain J Sainsbury ended down 1.6% even though Kantar Worldpanel's grocery market survey said that it was the only big four UK supermarket to increase sales in the past 12 weeks, for the second consecutive period.

Sainsbury's sales rose 0.9% in the 12 weeks to September 13 to GBP4.01 billion from GBP3.97 billion in the same period a year earlier, as its market share stayed flat at 16.2%.

Sainsbury's blue-chip peers, whose sales Kantar said were lower, ended heavily in the red, with Tesco and Wm Morrison Supermarkets down 4.3% and 4.5%, respectively.

In the FTSE 250, IG Group Holdings led the mid-cap gainers, up 2.6% after it said its revenue increased substantially in the first quarter against a weak comparative, but said the volatile market conditions make it difficult to predict an outcome for the full year.

The spread betting and contracts-for-difference company, which gives retail traders access to financial markets, said it is trading in line with its expectations at present, with revenue in the first quarter to the end of August up 24% to GBP106.0 million, though it noted the same period last year was "particularly subdued".

Meanwhile, US-focused science and technology development and commercialisation company Allied Minds ended down 15%. Its shares dropped after New York-based hedge fund Kerrisdale Capital outlined the reasons for its short position in the London stock.

Kerrisdale said Allied Minds has "no objective evidence of commercial success" in its portfolio and said its review of the company's subsidiaries "indicates that they are developing products that are, at best, minor variations on existing alternatives, often in the face of significant competition and without plausible business models."

In the corporate calendar Wednesday, Smiths Group releases full-year results, United Utilities issues a trading statement, and Gresham House publishes half-year results. Meanwhile, Pan African Resources releases full-year results, while Highland Gold Mining and Styles&Wood Group publish half-year results.

In the economic calendar, China's Caixin manufacturing Purchasing Manager's Index is due at 0245 BST. Germany's manufacturing and services PMI are expected at 0830 BST, while the same for the eurozone are due at 0900 BST. European Central Bank President Mario Draghi speaks at the European Parliament in Brussels at 1400 BST.

In the US, Markit manufacturing PMI is due at 1445 BST, while Energy Information Administration crude oil stocks are at 1530 BST. Atlanta Federal Reserve President Dennis Lockhart speaks at 1730 BST before the Columbus Rotary Club in the state of Georgia.

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.